Mount Sinai Researchers Awarded $3.15 Million to Advance a...

The National Cancer Institute has awarded Mount Sinai researchers $3.15 million in grant funding to assess the potential of a multidisciplinary drug development platform to identify new biological...(PRWeb November 30, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_researchers_awarded_3_15_million_to_advance_a_multidisciplinary_drug_development_platform_for_hepatocellular_carcinoma/prweb18364073.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news